Search

Paris will host the 6th World Congress on Targeting Phage Therapy 2023 this June More than 125 international participants from 27 different countries will be joining Targeting Phage Therapy 2023 on June 1-2 in Paris. During Targeting Phage

A European public consultation on a new general chapter in the European Pharmacopeia on phage therapy active substances and medicinal products of human and veterinary use is open (until end of June). This is a unique opportunity to help sha

IPATH's Translational Research in Bacteriophage Therapies Seminar Series has returned this year, featuring three speakers: Daria Van Tyne, Joseph Bondy-Denomy, and Austen Terwilliger. Watch recordings of them on YouTube, and catch upcoming

In this episode of Phage Therapy Today podcast, Dr. Gina Suh shares her recent progress and experience in applying phage therapy at Mayo Clinic.

Check out the Special Issue "The Phage: Biology and Therapeutic Use," published by Microorganisms and edited by Richard James (University of Nottingham) and David R. Harper (Evolution Biotechnologies). The deadline for manuscript submission

The Oxford Phage Meeting (Sept 4th-5th) is happening this year.

The Molecular Genetics of Bacteria and Phages Meeting in Madison, Wisconsin (Aug 7th-11th) is happening this year.

When the CDC reported a recent outbreak of extensively drug-resistant (XDR) Pseudomonas aeruginosa linked to artificial tears, IPATH's Co-Director, Chip Schooley, requested the Pseudomonas isolates associated with the outbreak. Fortunately,

Yunha Hwang and colleagues found that virus-host interactions in dense hydrothermal mats involve crossing microbial domains and nested metabolisms. They saw that unrelated microbes encode CRISPR immunity against the same viruses, suggesting

Nikhil George & Laura Hug examined a landfill via virus-host CRISPR spacer mapping, and found multiple examples of atypical virus-host dynamics, such as hyper-targeted viral populations, interviral conflicts, and non-specific viruses.

Tram Le and colleagues show the therapeutic potential of IV phage for recurrent urinary tract infections, describing a kidney transplant recipient with ESBL Klebsiella pneumoniae who was successfully treated with 4 weeks of IV phage therapy

Olaya Rendueles and colleagues have described how fitness costs drive competition between lysogenic and sensitive bacteria by co-cultivating a phage-sensitive strain and a polylysogenic Klebsiella pneumoniae strain under different phage pre

The Theoretical Biology and Bioinformatics group at Utrecht University is seeking a PhD candidate to join a new research group headed by Dr. Bram van Dijk, which will specialize in building multi-scale simulations of microbial ecosystems. T

The Department of Molecular and Cell Biology (MCB) at the University of Connecticut (UConn) in Storrs seeks to fill a non-tenure track PhD Research and Teaching Scholar position starting August 2023. They invite applicants interested in dsD

The Division of Gastroenterology at UC San Diego is seeking a Research Associate to perform cellular and animal lab experiments, develop multiple research projects about intestinal microbiota and its relationship with liver disease, and des

Phagos, a French biotech company that raised $2.4 in 2022 to make custom phages for agriculture is hiring for several positions.

[Senior Research Technician](Please shahttps://jobs.nottingham.ac.uk/vacancy.aspx?ref=MED150823) at University of Nottingham, UK in Nottingham The person appointed will be working in a busy research environment which carries out high impact

This week Jessica Sacher continues her 'qPCR for phage therapy' series. She takes us through how we know if our qPCR worked, what to look for, and how to interpret how much phage/bacteria were in our samples based on the results. Welcome to

Top Agar Question This is a basic question but one I do need advice with. My high school phage team will begin looking for a phage next fall from a new host. The host has not been studied much for phages. How do you choose a top agar for n

Phages seem to be saving lives left and right, but still, they remain unapproved drugs in most countries. Pharma companies don't sell them; hospitals and pharmacies don’t stock them. In this Wired article, Maryn McKenna covers phage therapy